Exercise before and during chemotherapy may boost treatment success
NCT ID NCT07502963
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a supervised exercise program, started two weeks before chemotherapy and continued for 16 weeks during treatment, can help adults aged 35 to 65 with breast, lung, or colon cancer tolerate chemotherapy better. The goal is to see if participants can receive more than 85% of their planned chemotherapy dose and achieve a higher rate of complete tumor disappearance. Seventy participants will be randomly assigned to either the exercise program or usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
supervised exercise program
What this could lead to
If it works, this could show that a structured exercise program helps patients complete more of their chemotherapy and potentially improve treatment response.
What could go wrong
This is a small, early-stage trial with only 70 participants, so results may not apply to everyone. Exercise may not significantly improve chemotherapy tolerance or outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Consorci Hospitalari de Vic
Vic, Barcelona, 08500, Spain
Contact Phone: •••-•••-••••
-
Facultat de Ciències de la Salut i del Benestar de la Universitat de Vic (UVIC-UCC) Universitat de Vic- Universitat Central de Catalunya
Vic, Barcelona, 08500, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitari de la Santa Creu
Vic, Barcelona, 08500, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••